January 4, 2018
Allergan cuts more than 1000 jobs due to competition
Alergan will have to cut over 1000 jobs from commercial and other functions, the company said on Wednesday.
Pharmaceuticals, Biotechnology and Life Sciences
Alergan will have to cut over 1000 jobs from commercial and other functions, the company said on Wednesday.
GSK on Wednesday set out several announcements made by the company to improve the efficiency and competitiveness of its manufacturing network, including investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews. This includes the sale of several products and a proposal to close a UK manufacturing site.
Roche’s Media Spokesperson, Dr. Ulrike Engels-Lange, said in an email sent to Pharmaceutical Daily that the site exits are expected to affect approximately 1,200 positions.